Evidence map›Paper›PMID 40805154›Full record

ArticleCancers2025

Monte Carlo Gradient Boosted Trees for Cancer Staging: A Machine Learning Approach.

Audrey Eley, Thu Thu Hlaing, Daniel Breininger, Zarindokht Helforoush, Nezamoddin N Kachouie

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Audrey EleyDepartment of Mathematics and Systems Engineering, Florida Institute of Technology, Melbourne, FL 32901, USA.
Thu Thu HlaingDepartment of Mathematics and Systems Engineering, Florida Institute of Technology, Melbourne, FL 32901, USA.
Daniel BreiningerDepartment of Mathematics and Systems Engineering, Florida Institute of Technology, Melbourne, FL 32901, USA.
Zarindokht HelforoushDepartment of Mathematics and Systems Engineering, Florida Institute of Technology, Melbourne, FL 32901, USA.
Nezamoddin N KachouieDepartment of Mathematics and Systems Engineering, Florida Institute of Technology, Melbourne, FL 32901, USA.ORCID 0000-0001-9397-1807

Funding

Florida Department of Health MOAAT
6 · The paper itself

Abstract

Machine learning algorithms are commonly employed for classification and interpretation of high-dimensional data. The classification task is often broken down into two separate procedures, and different methods are applied to achieve accurate results and produce interpretable outcomes. First, an effective subset of high-dimensional features must be extracted and then the selected subset will be used to train a classifier. Gradient Boosted Trees (GBT) is an ensemble model and, particularly due to their robustness, ability to model complex nonlinear interactions, and feature interpretability, they are well suited for complex applications. XGBoost (eXtreme Gradient Boosting) is a high-performance implementation of GBT that incorporates regularization, parallel computation, and efficient tree pruning that makes it a suitable efficient, interpretable, and scalable classifier with potential applications to medical data analysis. In this study, a Monte Carlo Gradient Boosted Trees (MCGBT) model is proposed for both feature reduction and classification. The proposed MCGBT method was applied to a lung cancer dataset for feature identification and classification. The dataset contains 107 radiomics which are quantitative imaging biomarkers extracted from CT scans. A reduced set of 12 radiomics were identified, and patients were classified into different cancer stages. Cancer staging accuracy of 90.3% across 100 independent runs was achieved which was on par with that obtained using the full set of 107 radiomics, enabling lean and deployable classifiers.

Indexed as

Gradient Boosted Treesimbalanced datasetlung cancerMonte CarloradiomicsXGBoost

Identifiers

PMID40805154
PMCPMC12346472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.